Sponsor Check › Person
Related person on Form D filings · address state as listed: MA · listed Nov 13, 2009 → Oct 15, 2025
Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:56 PM ET · SEC enforcement last checked: not yet
Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
None found in sources searched.
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:56 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
Search queued. Results are added automatically; check back later or follow this page to be notified.
None found in sources searched.
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:56 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons are made for sponsors and sponsor groups, not individual people.
3 of 13 offerings report sales commissions totalling $1,475,711; 0 report finder's fees; 0 report proceeds to related persons.
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Oct 15, 2025 D File 021-560942 | $351,897 | $0 | $0 While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to executive officers and to paying director stipends. | Lake Street Capital Markets, LLC BrokerCheck CRD 000164447 ↗ |
| EDGAR ↗ | Nov 4, 2021 D File 021-419911 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 23, 2021 D File 021-410958 | $860,001 | $0 | $0 Some of the proceeds may be used for working captial and other general corporate purposes, which may include the payment of salaries and other fees to those listed in item 3. | H.C. Wainwright & Co., LLC BrokerCheck CRD 375 ↗ |
| EDGAR ↗ | Jan 21, 2021 D File 021-386998 | $0 | $0 | $0 Some of the proceeds may be used for working capital and other general corporate purposes, which may include the payment of salaries and other fees to those listed in Item 3. | None listed on this filing |
| EDGAR ↗ | Jan 4, 2021 D File 021-385028 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 15, 2020 D File 021-358165 | $0 | $0 | $0 | H.C. Wainwright & Co., LLC BrokerCheck CRD 375 ↗ |
| EDGAR ↗ | Oct 8, 2019 D File 021-350635 | $0 | $0 | $0 Some of the proceeds may be used for working capital and other general corporate purposes, which may include the payment of salaries and other fees to those listed in Item 3. | None listed on this filing |
| EDGAR ↗ | Jul 7, 2016 D File 021-266554 | $263,813 | $0 | $0 Some of the proceeds may be used for working capital and other general corporate purposes, which may include the payment of salaries and other fees to those listed in Item 3. | H.C. Wainwright & Co., LLC BrokerCheck CRD 375 ↗ |
| EDGAR ↗ | Mar 21, 2016 D File 021-259702 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 24, 2014 D File 021-221723 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 26, 2013 D File 021-203605 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 5, 2011 D File 021-153029 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 21, 2009 D File 021-93705 | $0 | $0 | $0 | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
| Source | Issuer | Role | Filed | Form | Offering | Sold | Investors | Min. investment |
|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | Vicarious Surgical Inc. group: Vicarious Surgical | Executive Officer, Director Chief Executive Officer | Oct 15, 2025 | D | $11,730,000 similar: $829,831–$9,999,998 | $11,730,000 | 1 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | KIORA PHARMACEUTICALS INC | Executive Officer, Director Executive Chairman | Nov 4, 2021 | D | Indefinite similar: $1,694,259–$16,000,000 | $67,258 | 6 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | KIORA PHARMACEUTICALS INC | Executive Officer, Director Executive Chairman | Aug 23, 2021 | D | $10,750,013 similar: $1,694,259–$16,000,000 | $10,750,013 | 14 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | KIORA PHARMACEUTICALS INC | Executive Officer, Director President and Chief Executive Officer | Jan 21, 2021 | D | $8,000,003 similar: $1,694,259–$16,000,000 | $8,000,003 | 1 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | KIORA PHARMACEUTICALS INC | Executive Officer, Director President and Chief Executive Officer | Jan 4, 2021 | D | Indefinite similar: $1,694,259–$16,000,000 | $3,203,083 | 15 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | KIORA PHARMACEUTICALS INC | Executive Officer, Director | Jan 15, 2020 | D | Indefinite similar: $1,694,259–$16,000,000 | $0 | 5 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | KIORA PHARMACEUTICALS INC | Executive Officer, Director President and CEO | Oct 8, 2019 | D | $1,875,000 similar: $1,694,259–$16,000,000 | $1,875,000 | 1 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | KIORA PHARMACEUTICALS INC | Executive Officer, Director President and CEO | Jul 7, 2016 | D | $3,768,750 similar: $1,694,259–$16,000,000 | $3,768,750 | 2 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | KIORA PHARMACEUTICALS INC | Executive Officer, Director | Mar 21, 2016 | D | $2,618,797 similar: $1,694,259–$16,000,000 | $2,618,797 | 32 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | KIORA PHARMACEUTICALS INC | Executive Officer | Jul 24, 2014 | D | $2,000,000 similar: $2,000,000–$19,999,994 | $994,843 | 18 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | KIORA PHARMACEUTICALS INC | Executive Officer, Director | Sep 26, 2013 | D | $1,448,264 similar: $2,000,000–$19,999,994 | $968,971 | 21 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | KIORA PHARMACEUTICALS INC | Executive Officer, Director | Jan 5, 2011 | D | $4,450,648 | $4,450,648 | 9 | $9,999 |
| EDGAR ↗ | KIORA PHARMACEUTICALS INC | Executive Officer, Director | Dec 21, 2009 | D | $22,641,695 | $11,081,232 | 20 | $1 |
| EDGAR ↗ | KIORA PHARMACEUTICALS INC | Director, Executive Officer | Nov 13, 2009 | D | $490,000 | $490,000 | 4 | $1 |
Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); Pharmaceuticals / 506(b) (800 filings); Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
People and management entities the issuers listed as related persons on the same Form D filings as Stephen From. Source: the EDGAR rows in the table above.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period)
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Stephen From appears on a new Form D, or when a court case or SEC action is matched to them. See plans →